SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla reports 41% rise in Q4 consolidated net profit

12 May 2023 Evaluate

Cipla has reported results for fourth quarter (Q4) and year ended March 31, 2023.

The company has reported 45.56% fall in its net profit at Rs 355.49 crore for the quarter under review as compared to Rs 652.96 crore for the same quarter in the previous year. Total income of the company decreased by 0.92% at Rs 4013.45 crore for Q4FY23 as compared to Rs 4050.90 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 40.68% rise in its net profit at Rs 521.51 crore for fourth quarter ended March 31, 2023 as compared to Rs 370.70 crore for the same quarter in the previous year. Total income of the company increased by 10.32% at Rs 5873.93 crore for Q4FY23 as compared to Rs 5324.35 crore for the corresponding quarter previous year.

For the year ended March 31, 2023, the company has reported 15.03% fall in its net profit at Rs 2513.47 crore as compared to Rs 2957.93 crore for the previous year. However, total income of the company increased by 1.25% at Rs 16247.39 crore for year under review as compared to Rs 16047.52 crore for year ended March 31, 2022.

For the year ended March 31, 2023, on the consolidated basis, the company has reported 11.24% rise in its net profit at Rs 2832.89 crore as compared to Rs 2546.65 crore for the previous year. Total income of the company increased by 5.37% at Rs 23228.57 crore for year under review as compared to Rs 22044.25 crore for year ended March 31, 2022.

Cipla Share Price

1236.25 -2.05 (-0.17%)
20-Apr-2026 10:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1674.25
Dr. Reddys Lab 1235.85
Cipla 1236.25
Zydus Lifesciences 941.20
Lupin 2336.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×